Related Experiment Video
Updated: Aug 30, 2026

Determining Pain Detection and Tolerance Thresholds Using an Integrated, Multi-Modal Pain Task Battery
Published on: April 14, 2016
Tanning facility use: are we exceeding Food and Drug Administration limits?
Robin L Hornung1, Kristin H Magee, Willie J Lee
1Division of Dermatology, Department of Pediatrics, University of Washington School of Medicine, Seattle, WA 98105, USA. robin.hornung@seattlechildrens.org
Background:
The US Food and Drug Administration (FDA) recommends exposure limits for tanning bed use. Tanning patrons may not be following these recommendations and may be overexposed to damaging ultraviolet radiation (UV).
Objective:
This study was conducted to assess tanning patrons' adherence to FDA-recommended exposure limits and to measure the amount of UVA and UVB radiation emitted by tanning beds.
Methods:
A community-based survey was administered during routine state inspections of North Carolina tanning facilities (n = 50). At each facility, patron records were randomly selected (n = 483) for a survey of exposure records, and UVA and UVB outputs were measured for each tanning bed.
Results:
The recommended limits were exceeded by 95% of patrons, and 33% of patrons began tanning at the maximum doses recommended for maintenance tanning. Average tanning bed output was 192.1 W/m(2) UVA and 0.35 W/m(2) erythemally weighted UVB.
Conclusions:
Interventions for tanning bed operators and patrons are needed to increase compliance with federally recommended exposure limits.
More Related Videos
Related Concept Videos
Drug Regulation
FDA Approved Drugs: Changes to Approved Drugs
Toxicity Testing in Animals
Therapeutic Drug Monitoring: Drug Analysis Methods

